Sensydia Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Series D

  • Latest Deal Amount
  • $8.9M

  • Investors
  • 5

Sensydia General Information

Description

Developer of a non-invasive cardiac assessment device designed to simplify and improve the measurement of advanced hemodynamic parameters. The company's device offers an AI-powered system that delivers real-time cardiac output, ejection fraction, and pulmonary pressure readings using disposable sensors and cloud connectivity, enabling clinicians in hospitals, clinics, and outpatient settings to detect heart conditions, guide treatment decisions, and reduce reliance on invasive procedures.

Contact Information

Website
www.sensydia.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 25020 Avenue Stanford
  • Suite 50
  • Valencia, CA 91355
  • United States
+1 (877)
Primary Industry
Diagnostic Equipment
Other Industries
Monitoring Equipment
Decision/Risk Analysis
Vertical(s)
Digital Health, Wearables & Quantified Self, Artificial Intelligence & Machine Learning, HealthTech
Corporate Office
  • 25020 Avenue Stanford
  • Suite 50
  • Valencia, CA 91355
  • United States
+1 (877)

Sensydia Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sensydia Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC (Series D) 19-Oct-2026 $8.9M Completed Clinical Trials - General
6. Grant 05-Jun-2023 Completed Clinical Trials - General
5. Later Stage VC (Series D) 09-May-2023 Completed Clinical Trials - General
4. Accelerator/Incubator 20-Mar-2023 Completed Clinical Trials - General
3. Later Stage VC (Series C) 18-Aug-2020 Completed Clinical Trials - General
2. Early Stage VC (Series B) 02-Aug-2017 $3.73M $5.73M Completed Clinical Trials - General
1. Early Stage VC (Series A) 16-Mar-2016 $2M $2M Completed Clinical Trials - General
To view Sensydia’s complete valuation and funding history, request access »

Sensydia Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series D3 Prime
Series D3
Series D2
Series D1
Series C
Series B 5,402,000 $0.000010 6% $0.69 $0.69 1x $0.69 9.85%
Series A 5,628,910 $0.000010 6% $0.35 $0.35 1x $0.35 10.27%
To view Sensydia’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Sensydia Patents

  • 5

    Total Documents Applications and Grants

  • Total Patents Families

  • 2

    Granted

  • Pending

  • Expiring in next 12 mo

Sensydia Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-12727768-B2 Phonocardiogram (pcg) signal processing systems and methods for determining cardiac tissue and valvular blood flow parameters Active 18-Apr-2022
US-20230329563-A1 Phonocardiogram (pcg) signal processing systems and methods for determining cardiac tissue and valvular blood flow parameters Active 18-Apr-2022
WO-2023205047-A1 Phonocardiogram (pcg) signal processing systems and methods for determining cardiac tissue and valvular blood flow parameters Inactive 18-Apr-2022
US-20220304631-A1 Multisensor pulmonary artery and capillary pressure monitoring system Inactive 29-Mar-2021
WO-2022211972-A1 Multisensor pulmonary artery and capillary pressure monitoring system Inactive 29-Mar-2021 A61B7/04
To view Sensydia’s complete patent history, request access »

Sensydia Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sensydia Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
National Institutes of Health Government
Orlando Health Ventures Corporate Venture Capital Minority
MassChallenge Accelerator/Incubator
Colle Capital Partners Venture Capital Minority
Frontier Venture Capital Venture Capital Minority
To view Sensydia’s complete investors history, request access »

Ready to get started?

Request a free trial

Sensydia FAQs

  • When was Sensydia founded?

    Sensydia was founded in 2015.

  • Where is Sensydia headquartered?

    Sensydia is headquartered in Valencia, CA.

  • What is the size of Sensydia?

    Sensydia has 10 total employees.

  • What industry is Sensydia in?

    Sensydia’s primary industry is Diagnostic Equipment.

  • Is Sensydia a private or public company?

    Sensydia is a Private company.

  • What is the current valuation of Sensydia?

    The current valuation of Sensydia is .

  • What is Sensydia’s current revenue?

    The current revenue for Sensydia is .

  • How much funding has Sensydia raised over time?

    Sensydia has raised $26.8M.

  • Who are Sensydia’s investors?

    National Institutes of Health, Orlando Health Ventures, MassChallenge, Colle Capital Partners, and Frontier Venture Capital have invested in Sensydia.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process